MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,991,526 | -29.7% | 109,501 | +11.3% | 0.01% | -16.7% |
| Q2 2023 | $22,734,558 | +2.4% | 98,418 | +7.4% | 0.01% | -14.3% |
| Q1 2023 | $22,196,346 | -16.4% | 91,622 | +0.2% | 0.01% | -22.2% |
| Q4 2022 | $26,543,363 | +356.4% | 91,450 | +2.2% | 0.01% | +350.0% |
| Q3 2022 | $5,816,000 | -7.9% | 89,479 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $6,317,000 | -27.2% | 88,250 | -0.3% | 0.00% | -33.3% |
| Q1 2022 | $8,682,000 | +18.1% | 88,474 | +2.0% | 0.00% | +50.0% |
| Q4 2021 | $7,349,000 | +11.1% | 86,718 | +4.6% | 0.00% | 0.0% |
| Q3 2021 | $6,613,000 | -6.1% | 82,868 | +14.6% | 0.00% | 0.0% |
| Q2 2021 | $7,041,000 | -6.5% | 72,282 | +12.3% | 0.00% | -33.3% |
| Q1 2021 | $7,529,000 | +12.5% | 64,359 | +6.9% | 0.00% | 0.0% |
| Q4 2020 | $6,692,000 | -5.0% | 60,188 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $7,043,000 | +0.9% | 59,315 | -3.7% | 0.00% | 0.0% |
| Q2 2020 | $6,979,000 | +79.5% | 61,622 | +5.8% | 0.00% | +50.0% |
| Q1 2020 | $3,889,000 | -22.1% | 58,240 | +6.3% | 0.00% | -33.3% |
| Q4 2019 | $4,994,000 | +19.8% | 54,809 | +13.4% | 0.00% | +50.0% |
| Q3 2019 | $4,168,000 | -16.0% | 48,332 | +2.1% | 0.00% | -33.3% |
| Q2 2019 | $4,960,000 | -11.8% | 47,317 | +5.4% | 0.00% | -25.0% |
| Q1 2019 | $5,623,000 | +17.8% | 44,890 | +6.0% | 0.00% | 0.0% |
| Q4 2018 | $4,773,000 | -48.1% | 42,337 | -1.4% | 0.00% | -33.3% |
| Q3 2018 | $9,195,000 | +146.8% | 42,938 | +222.4% | 0.01% | +100.0% |
| Q2 2018 | $3,726,000 | +221.2% | 13,320 | +34.2% | 0.00% | +200.0% |
| Q1 2018 | $1,160,000 | +43.0% | 9,928 | +12.5% | 0.00% | 0.0% |
| Q4 2017 | $811,000 | +30.6% | 8,828 | -36.0% | 0.00% | 0.0% |
| Q3 2017 | $621,000 | +176.0% | 13,800 | 0.0% | 0.00% | – |
| Q2 2017 | $225,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |